(Q46932993)

English

The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

0 references

author name string

Jirí Kassa

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

Neurotoxicity Research

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

59-62

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

https://scigraph.springernature.com/pub.10.1007/bf03033308

0 references

Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro reactivation of acetylcholinesterase using the oxime K027.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of the time of antidotal treatment administration on its effectiveness against tabun-induced poisoning in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of anticholinergic drug selection on the effectiveness of oximes against soman-induced supralethal poisoning in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of anticholinergic drugs and brain muscarinic receptor alterations in streptozotocin diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16464753

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03033308

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

release_uoelon36prfjdf36ojnwo4fmuy

1 reference

https://api.fatcat.wiki/v0/release/uoelon36prfjdf36ojnwo4fmuy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16464753

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46932993&oldid=2138495532"